论文部分内容阅读
目的探讨艾迪注射液配合放化疗治疗非小细胞肺癌的临床效果。方法抽取水矿控股集团总医院2010年1月至2013年1月收治的26例经艾迪注射液配合放化疗治疗的非小细胞肺癌患者作为观察组,并抽取同期我院收治的26例经单纯放化疗治疗的非小细胞肺癌患者作为对照组,分析和比较两组临床治疗情况。结果经治疗后发现,观察组共有23例得到有效治愈,总有效率为88.5%,明显优于对照组的73.1%(19例),两组比较差异有统计学意义(P<0.05)。结论经研究发现,艾迪注射液配合放化疗治疗非小细胞肺癌,能够起到益气滋阴、提高免疫功能的作用,临床疗效更显著,值得进一步推广。
Objective To investigate the clinical effect of Aidi injection combined with radiotherapy and chemotherapy in the treatment of non-small cell lung cancer. Methods Twenty-six patients with non-small cell lung cancer treated with Aidi injection combined with radiotherapy and chemotherapy were selected as the observation group from January 2010 to January 2013 in the General Hospital of Shuida Holding Group, and 26 cases treated in our hospital during the same period were collected. Non-small cell lung cancer patients treated with radiotherapy and chemotherapy alone were used as a control group. The clinical treatment of the two groups was analyzed and compared. Results After treatment, a total of 23 cases in the observation group were effectively cured, and the total effective rate was 88.5%, which was significantly better than that of the control group (73.1%) (19 cases). There was a statistically significant difference between the two groups (P<0.05). Conclusion After the study found that Aidi injection combined with radiotherapy and chemotherapy in the treatment of non-small cell lung cancer, can play the role of Qi and yin, improve immune function, clinical efficacy is more significant, it is worth further promotion.